December 17, 2021

DHVI Awarded $365 million NIAD Contract for Vaccine Development

DURHAM, N.C. – The National Institute of Allergy and Infectious Diseases awarded researchers at the Duke Human Vaccine Institute a contract that enables it to compete for projects advancing investigational vaccines to production for use in early clinical trials.

To read the full story from Duke Health, click here.